ATE453398T1 - Neuartige pharmakologische aktivitäten von curcuma longa extrakten - Google Patents

Neuartige pharmakologische aktivitäten von curcuma longa extrakten

Info

Publication number
ATE453398T1
ATE453398T1 AT00964281T AT00964281T ATE453398T1 AT E453398 T1 ATE453398 T1 AT E453398T1 AT 00964281 T AT00964281 T AT 00964281T AT 00964281 T AT00964281 T AT 00964281T AT E453398 T1 ATE453398 T1 AT E453398T1
Authority
AT
Austria
Prior art keywords
pharmacological activities
curcuma longa
novel pharmacological
longa extracts
extracts
Prior art date
Application number
AT00964281T
Other languages
English (en)
Inventor
Almagro Eliseo Quintanilla
Bosca Ana Ramirez
August Bernd
Zapata Jose Pardo
Alperi Joaquin Diaz
Mira David Pamies
Gutierrez Miguel Angel Carrion
Ortells Jose Miguel Sempere
Original Assignee
Asac Compania De Biotecnologia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asac Compania De Biotecnologia filed Critical Asac Compania De Biotecnologia
Application granted granted Critical
Publication of ATE453398T1 publication Critical patent/ATE453398T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00964281T 1999-09-23 2000-09-21 Neuartige pharmakologische aktivitäten von curcuma longa extrakten ATE453398T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902364A ES2154610B1 (es) 1999-09-23 1999-09-23 Nuevas actividades farmacologicas de los extractos de curcuma longa.
PCT/ES2000/000354 WO2001021185A1 (es) 1999-09-23 2000-09-21 Nuevas actividades farmacologicas de los extractos de curcuma longa

Publications (1)

Publication Number Publication Date
ATE453398T1 true ATE453398T1 (de) 2010-01-15

Family

ID=8310389

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00964281T ATE453398T1 (de) 1999-09-23 2000-09-21 Neuartige pharmakologische aktivitäten von curcuma longa extrakten

Country Status (9)

Country Link
US (1) US6841177B1 (de)
EP (1) EP1133992B1 (de)
JP (1) JP2003509464A (de)
AT (1) ATE453398T1 (de)
AU (1) AU7525300A (de)
CA (1) CA2351482A1 (de)
DE (1) DE60043609D1 (de)
ES (3) ES2154615B1 (de)
WO (1) WO2001021185A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002063982A1 (en) * 2001-02-09 2002-08-22 New Chapter, Inc. Composition and method for smoke detoxification
AU2005229008B2 (en) * 2004-03-23 2011-03-24 Lifeline Nutraceuticals Corporation Compositions and method for alleviating inflammation and oxidative stress in a mammal
US9265808B2 (en) 2004-03-23 2016-02-23 Lifeline Nutraceuticals Corporation Compositions for alleviating inflammation and oxidative stress in a mammal
WO2008010697A1 (es) * 2006-07-19 2008-01-24 Herrera Ramirez Mario Alberto Fármaco a base de curcumina para el tratamiento de infección parasitaria provocada por la giardia lamblia
CN101686725A (zh) 2007-04-03 2010-03-31 刚迦·拉贾·高卡拉贾 消炎和抗氧化协同作用的膳食补充组合物
BRPI0818178B1 (pt) * 2007-10-03 2021-11-23 Sabell Corporation Composições herbais para tratar distúrbios hepáticos e método para obter extratos hidroalcoólicos de um órgão de planta selecionado
WO2009066303A2 (en) 2007-11-22 2009-05-28 Ganga Raju Gokaraju New synergistic phytochemical composition for the treatment of obesity
JP6062616B2 (ja) * 2007-12-21 2017-01-18 アサク コンパーニャ デ ビオテクノロヒア エ インベスティガシオン，ソシエダ アノニマ クルクミノイド及びこれらの類似体の治療有効性を改善するための方法
WO2009080842A1 (es) * 2007-12-21 2009-07-02 Asac Compañía De Biotecnología E Investigación Sa Composiciones fotoprotectoras
MY174568A (en) * 2013-12-31 2020-04-27 Sirim Berhad A bioactive composition having natural uv photoprotective properties
CN104888098A (zh) * 2015-05-04 2015-09-09 孙著叶 一种用于关节置换后静脉血栓的中药制剂及制备方法
JP7209691B2 (ja) * 2017-07-24 2023-01-20 サミ－サビンサ グループ リミテッド ウコン残渣物、その方法および組成物
CN107596252A (zh) * 2017-09-04 2018-01-19 中国科学院化学研究所 姜黄提取物及其制备方法、用途和保健品
JP6709001B1 (ja) * 2019-07-01 2020-06-10 ハウスウェルネスフーズ株式会社 ＴＮＦ−α又はＩＬ−６産生抑制用組成物
KR102327827B1 (ko) * 2019-11-01 2021-11-18 한국과학기술연구원 강황 추출물을 유효성분으로 포함하고 자외선 처리를 포함하는 건선 개선용 조성물
FR3104947B1 (fr) * 2019-12-18 2022-11-25 Fabre Pierre Dermo Cosmetique Extrait de Curcuma longa sans curcuminoïde, dans les dermatoses inflammatoires
CN111166847B (zh) * 2019-12-23 2021-12-31 成都锦华药业有限责任公司 一种含姜黄的药物组合物及其片剂和制备方法
RU2760551C1 (ru) * 2020-06-17 2021-11-29 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ лечения радиационных поражений организма и способ получения биологического препарата для лечения радиационных поражений организма

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4137540A1 (de) * 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
WO1996003999A1 (es) * 1994-08-03 1996-02-15 A.S.A.C. Pharmaceutical International, A.I.E. Procedimiento para la obtencion de extractos apolares y polares de curcuma y aplicaciones de los mismos
US5891924A (en) * 1996-09-26 1999-04-06 Research Development Foundation Curcumin (diferuloylmethane) inhibition of NFκB activation
US6019735A (en) * 1997-08-28 2000-02-01 Visco Technologies, Inc. Viscosity measuring apparatus and method of use
US20020164374A1 (en) * 1997-10-29 2002-11-07 John Jackson Polymeric systems for drug delivery and uses thereof

Also Published As

Publication number Publication date
DE60043609D1 (de) 2010-02-11
WO2001021185A1 (es) 2001-03-29
ES2154610A1 (es) 2001-04-01
EP1133992A1 (de) 2001-09-19
US6841177B1 (en) 2005-01-11
EP1133992B1 (de) 2009-12-30
JP2003509464A (ja) 2003-03-11
AU7525300A (en) 2001-04-24
ES2157862A1 (es) 2001-08-16
ES2154610B1 (es) 2001-11-16
CA2351482A1 (en) 2001-03-29
ES2157862B1 (es) 2002-03-01
ES2154615A1 (es) 2001-04-01
ES2154615B1 (es) 2001-11-16

Similar Documents

Publication Publication Date Title
ATE453398T1 (de) Neuartige pharmakologische aktivitäten von curcuma longa extrakten
ATE229272T1 (de) Desinfizierende zusammensetzung auf basis von h2o2, säuren und metallionen
FI962350A (fi) BPM-12, BMP-13 sekä niiden jännettä indusoivat koostumukset
DE60133802D1 (de) Verwendung von säurestabilen proteasen in tierfutter
ATE245417T1 (de) Pharmazeutische zubereitungen auf der basis von levodopa, carbidopa und entacapone
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
DK0921812T3 (da) Insulinpræparater, som indeholder NaCi
ATE396197T1 (de) 17-alpha-substituierte-11-beta-substituierte-4- aryl und 21-substituierte 19-norpregnadienedione mit antigestagener aktivität
ES2167401T3 (es) Uso de ascorbil-gamma-linolenato o un ascorbil-dihomo-gamma-linolenato para el tratamiento de asma, cancer, enfermedades cardiovasculares y anti-inflamatorias.
CY1108835T1 (el) Θεραπευτικες χρησεις αγωνιστων και ανταγωνιστων της il174
EE9900477A (et) Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks
FI931204A (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
ATE411802T1 (de) Kombinationspräparate von 1,4- benzothiepin-1,1- dioxidderivaten mit weiteren wirkstoffen und deren verwendung
DE59409104D1 (de) Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
DE69803925D1 (de) Methode zur kalt-sterilisation von öfen des tunnel-typs im pharmazeutischen bereich und öfen zur anwendung dieser methode
IT1298376B1 (it) Trattamento di reticolazione e sterilizzazione per la produzione di manufatti in polietilene ad elevate caratteristiche tribologiche,
ES2052513T3 (es) Nuevos polipeptidos, su fabricacion y empleo.
ATE321772T1 (de) Echinocandinderivate, deren herstellung und deren verwendung zur bekämpfung von pilzen
TR199700435A2 (xx) Pestisit florolefin bile�imlerinin haz�rlanmas� i�in i�lem ve ara bile�imler.
DE60134885D1 (de) Antiangiogene polypeptide
DK0661058T3 (da) Anvendelse af bradykininantagonister til behandling af virussygdomme
ATE148105T1 (de) Succinoylaminohydroxyäthylaminosulfamidsäureder vate und ihre verwendung als retrovirale proteasehemmer
DE69825307D1 (de) Verwendung von protein h als zytostattischer wirkstoff
ATE375515T1 (de) Biochemische marker des menschlichen endometrium
ECSP961957A (es) Sales de carboxamidas de accion prolongada y estables para el tratamiento de las enfermedades de las articulaciones

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties